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Fossil remains from ~100 million years ago (Ma) show that snakes were widely distributed across the world by the late Cretaceous period1. During the course of their evolution, 
snakes lost their limbs, acquiring a serpentine body2. Some also 
evolved or co-opted venom systems to help subdue, capture and 
digest their prey2,3. The Colubroides clade of advanced snakes 
encompasses >3,000 extant species including >600 venomous spe-
cies4. The most venomous snakes include the true vipers and pit 
vipers, both members of the Viperidae family, and cobras, kraits, 
mambas and sea snakes from the Elapidae family5.
Although humans are not an intended target, accidental con-
tact with venomous snakes can be deadly. Snakebite envenom-
ing is a serious neglected tropical disease that affects ~5 million 
people worldwide annually, leading to ~400,000 amputations and 
>100,000 deaths6. In India alone, the high rural population density 
combined with the presence of the ‘big four’ deadly snakes, namely 
the Indian cobra (Naja naja), Russell’s viper (Daboia russelli), saw-
scaled viper (Echis carinatus) and common krait (Bungarus caeru-
leus), results in >46,000 snakebite-related deaths annually7.
Snake venom is a potent lethal cocktail rich in proteins and 
peptides, secreted by specialized venom gland cells. Venom com-
ponents can be broadly classified as neurotoxic, cytotoxic, cardio-
toxic or hemotoxic, and the composition can vary both between and 
within species8–11.
Currently, snake antivenom is the only treatment effective in the 
prevention or reversal of the effects of envenomation. Since 1896, 
antivenom has been developed by immunization of large mammals, 
such as the horse, with snake venom to generate a cocktail of anti-
bodies that are used for therapy12. Given the heterologous nature of 
these antibodies, they often elicit adverse immunological responses 
when treating snakebite victims13. Moreover, the antivenom com-
position is not well defined and its ability to neutralize the venom 
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Snakebite envenoming is a serious and neglected tropical disease that kills ~100,000 people annually. High-quality, genome-
enabled comprehensive characterization of toxin genes will facilitate development of effective humanized recombinant anti-
venom. We report a de novo near-chromosomal genome assembly of Naja naja, the Indian cobra, a highly venomous, medically 
important snake. Our assembly has a scaffold N50 of 223.35 Mb, with 19 scaffolds containing 95% of the genome. Of the 
23,248 predicted protein-coding genes, 12,346 venom-gland-expressed genes constitute the ‘venom-ome’ and this included 
139 genes from 33 toxin families. Among the 139 toxin genes were 19 ‘venom-ome-specific toxins’ (VSTs) that showed venom-
gland-specific expression, and these probably encode the minimal core venom effector proteins. Synthetic venom reconstituted 
through recombinant VST expression will aid in the rapid development of safe and effective synthetic antivenom. Additionally, 
our genome could serve as a reference for snake genomes, support evolutionary studies and enable venom-driven drug discovery.
NATuRE GENETICS | VOL 52 | JANUARY 2020 | 106–117 | www.nature.com/naturegenetics106
ArticlesNature GeNetics
components is poorly understood. This is further exacerbated by 
the lack of access to antivenom and its high cost in many develop-
ing countries14. Although several alternative approaches have been 
proposed, large animal-based antivenom production using extracted 
snake venom as the antigen continues to be the standard practice15–18.
High-quality genomes of venomous snakes, combined with 
transcriptomics, will enable generation of a comprehensive cata-
log of venom-gland-specific toxin genes that can be used for the 
development of synthetic antivenom of defined composition using 
recombinant technologies. Thus far, only a few snake genomes have 
been published. A majority of these were generated primarily using 
short-read sequencing resulting in highly fragmented assemblies, 
thus limiting their utility for creating a complete catalog of venom-
relevant toxin genes19–25. The ‘big four’ medically important snakes 
from India, including N. naja, are no exception and have not been 
well characterized at either the genome or transcriptome level. Only 
nine N. naja toxin gene sequences and 38 toxins, some of which 
probably represent the same gene, have been reported using mass 
spectrometry26.
In this study, using a number of genomic technologies, we have 
generated a de  novo near-chromosome level reference genome 
assembly of N. naja, the Indian cobra. This high-quality genome 
allowed us to study various aspects of snake venom biology, includ-
ing venom gene genomic organization, genetic variability, evolution 
and expression of key venom genes. Our integrated genome–tran-
scriptome analysis identified a minimal set of 19 VST genes that con-
stitute the core venom toxins. Targeting these core toxins should lead 
to the development of a safe and effective humanized antivenom.
Results
Near-chromosomal de novo genome assembly. Using flow cytom-
etry, we estimated the size of the Indian cobra haploid genome at 
1.48–1.77 Gb (Extended Data Fig. 1). Cytogenetic analysis revealed 
a diploid karyotype of 2n = 38, comprising seven pairs of macro-
chromosomes (MACs), one pair of sex chromosomes (ZZ male or 
ZW female) and 11 pairs of microchromosomes (MICs), consistent 
with a previous report27 (Extended Data Fig. 2).
DNA from an adult male Indian cobra (NN01) was used to 
generate long-read (PacBio and Oxford Nanopore Technologies 
(ONT)), short-read (Illumina), Chicago28, Hi-C29 and optical map-
ping (Bionano Genomics (BNG)) data (Supplementary Table 1a,b). 
Additionally, we generated linked-read 10x Genomics, BNG and 
short-read Illumina sequence data for a female animal (NN05; 
Supplementary Note and Supplementary Table 1a,b). Our sequen-
tial assembly approach (Fig. 1 and Supplementary Note) resulted 
in a 1.79-Gb Nana_v5 genome with a scaffold N50 of 223.35 Mb 
and a BUSCO30 genome completeness score of 94.3% (Table 1 and 
Supplementary Table 2a–c).
To assign scaffolds from Nana_v5 to chromosomes, we used 
complementary DNA (cDNA) chromosome marker sequences from 
a colubrid, the Japanese rat snake Elaphe quadrivirgata31 (Fig. 1e), 
synteny information from Anolis carolinensis (the green anole liz-
ard genome32) and single-chromosome sequencing data (SChrom-
seq; Fig. 1f, Supplementary Table 3a–c and Supplementary Note). 
We also generated a hybrid 10x BNG genome assembly to iden-
tify a 52.1-Mb female-specific W chromosome-linked scaffold 
(Supplementary Table 3d and Supplementary Note).
Comparison of the N. naja de  novo genome assembly to the 
human33 and goat34 genomes showed that the scaffold N50 of the 
N. naja genome was 2.5× (87.27 versus 223.35 Mb) and 3.3× (67.79 
versus 223.35 Mb) greater than the goat and human genomes pre-
viously assembled using the involved, expensive, time-consuming 
physical and cytogenetic maps developed over a decade or more 
(Table 2). Compared with the king cobra genome19, also an elapid, 
the Indian cobra genome contained far fewer scaffolds (296,399 ver-
sus 1,897, respectively), and had 929-fold better contiguity (scaffold 
N50 of 0.24 versus 223.35 Mb, respectively). Also, compared to the 
7,034 scaffolds and 179.89-Mb scaffold N50 reported recently for 
the prairie rattlesnake genome (Crotalus viridis)35, the Indian cobra 
genome had a higher scaffold N50 and fewer scaffolds (Table 2).
Genome features. The average DNA base (GC) content of the N. 
naja genome was 40.46%. While MACs, representing 88% of the 
genome, had a GC content of 39.83%, that of MICs was 43.50% 
despite their containing only 12% of the genome (Welch’s two-
sample t-test, two-sided P < 0.0001; Fig. 2a). Analysis of the repeat 
content in the Indian cobra genome in relation to other squamate 
reptile genomes revealed that 43.22% of the genome was repetitive 
(~760 Mb; Fig. 2a, Supplementary Table 4a,b, Extended Data Fig. 3 
and Supplementary Note).
Whole-genome synteny comparison between the Indian cobra 
and prairie rattlesnake genomes revealed large syntenic blocks 
between the macro-, micro- and Z-chromosomes (Fig. 2b,c). We 
observed several fusion/fission events consistent with the difference 
in chromosome number between these two genomes. In particular, 
chromosome 4 of the Indian cobra shared syntenic regions with rat-
tlesnake chromosomes 3 and 5, indicating a possible fusion event. 
In contrast, Indian cobra chromosomes 5 and 6 were syntenic to 
rattlesnake chromosome 5, indicating a possible fission event (Fig. 
2b,c). Comparison of the Indian cobra genome to that of the more 
distantly related green anole lizard also showed regions of synteny 
and chromosomal rearrangements (Fig. 2c). Lizard chromosome 2 
contained syntenic regions corresponding to chromosomes 4, 5 
and 6 in the Indian cobra genome (Fig. 2c). Our synteny analysis 
also showed that the lizard chromosome 6 is homologous to the 
Z-chromosome of the Indian cobra (Fig. 2c and Supplementary 
Table 3b)36. Despite an estimated divergence time of ~280 Ma 
between snake and chicken (Gallus gallus), we observed synteny 
between several macro- and microchromosomes. Several regions of 
chicken chromosomes 1 and 2 showed syntenic blocks across Indian 
cobra macro-, micro- and Z-chromosomes (Fig. 2c). This indicated 
large-scale changes in macro- and microchromosome organization 
between squamate and avian genomes during evolution31,37.
Gene prediction and annotation. We used the MAKER pipeline38 
to annotate the genome using protein homology information, 
in combination with gene expression data from 14 different tis-
sues (n = 26 samples; Figs. 2d and 3, Supplementary Table 1a and 
Supplementary Note). Overall, we predicted 23,248 protein-coding 
genes and 31,447 transcripts that included alternatively spliced 
products encoding 31,036 predicted proteins (Fig. 2d). Of the 
23,248 genes, we found 22,116 (95%) on the 19 largest scaffolds cor-
responding to the numbered chromosomes. A total of 26,216 of the 
31,036 predicted proteins (84.4%) contained a canonical start and 
stop codon. We identified 3,265 of 26,216 proteins (~12.5%) with an 
N-terminal secretion signal sequence, a feature important for venom 
gland toxin secretion (Supplementary Table 5). We performed 
extensive functional annotation of the 31,036 predicted proteins and 
found that 17,019 (54.8%) had a corresponding ortholog in either 
the Human Gene Nomenclature Committee database, NCBI’s non-
redundant database or the TrEMBL (https://www.ebi.ac.uk/uniprot) 
database (Supplementary Tables 5 and 7b and Supplementary Note). 
Comparison of our annotated proteome to that of the king cobra19, 
prairie rattlesnake35 and green anole lizard genomes32 identified 
26,323, 25,505 and 11,820 orthologs in those genomes, respectively.
We comprehensively annotated venom-gland-relevant genes 
by combining the predicted gene models with long-read sequenc-
ing data (Supplementary Table 6a and Supplementary Note), 
toxin gene hidden Markov models (HMM) and manual curation 
to identify 139 toxin genes from 33 gene families39 that included 
19 three-finger toxins (3FTxs), 8 snake venom metalloprotein-
ases (SVMPs) and 6 cysteine (Cys)-rich secretory venom proteins 
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(CRISPs) (Supplementary Table 6b). Near-chromosomal assembly 
also allowed us to assess the genomic organization of gene families 
that encoded enzymatic and non-enzymatic toxin proteins involved 
in venom gland function. In the N. naja genome, 16 major toxin 
gene families were organized on MACs (Fig. 4a and Supplementary 
Table 6c). This is in contrast to the genomes of viperids C. viridis 
(prairie rattlesnake) and Protobothrops flavoviridis (Amami habu), 
where a majority of the venom gland genes were found on MICs23,35.
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Fig. 1 | Schematic of N. naja genome sequencing and assembly. a,b, Long-read (PacBio and ONT) and short-read (lllumina) data (a) were used to build 
contigs that were then combined with Chicago28 chromatin interaction data (b) to generate scaffolds. c, Scaffolds from BNG optical mapping de novo 
assembly were combined with those from the previous step to generate super-scaffolds. d, Hi-C sequencing data were used to refine the assembly.  
e, Electronic fluorescence in situ hybridization (eFISH) was performed using cDNA FISH marker sequences from the Japanese rat snake, E. quadrivirgata.  
f, SChrom-seq data were used to assign scaffolds to chromosomes.
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Of the 19 full-length 3FTx genes identified in the genome, 14 
were clustered within a 6.3-Mb region on chromosome 3 (Fig. 
4b). One 3FTx gene (Nana001KS) was located on chromosome 4 
and the remaining four were found on an unassigned scaffold, 
ScVE01q_1072 (Supplementary Table 6c). Additionally, we identi-
fied 10 3FTx pseudogenes that lacked parts of the coding region and 
were not expressed. The second largest toxin gene family encoded 
by the N. naja genome consisted of eight SVMPs that were clustered 
on a MIC 1 (Fig. 4c). A cluster of six CRISPs were found on chromo-
some 1 (Fig. 4d). Other toxin genes, including natriuretic peptide, 
C-type lectin, snake venom serine proteinase (SVSP), Kunitz and 
venom complement-activating gene families, were found to be dis-
tributed across the 19 chromosomes while two group I Phospholipase 
A2 (PLA2) genes and one cobra venom factor (CVF) gene were 
located on an unassigned scaffold (ScVE01q_344; Supplementary 
Table 6c). Comparisons of venom gland genes between the C. viri-
dis genome and that of the Indian cobra identified 15 toxin gene 
families that were unique to the Indian cobra. This included phos-
pholipase B-like toxins and cathlecidins40,41 (Supplementary Table 
6d). Assessment of the 139 Indian cobra venom gland toxin genes 
for orthologs in the king cobra showed that, while 96 genes had a 
match, 43 did not (Supplementary Table 6e). Although some of the 
43 toxins are likely to be unique to the Indian cobra, a majority were 
not annotated in the king cobra genome probably due to its highly 
fragmented assembly (Table 2).
Synteny comparisons of the major toxin gene families (3FTx, 
SVMP and CRISP) in genomes of the Indian cobra, prairie rattle-
snake and green anole lizard revealed multiple duplication events in 
each family involving a paralog of non-venomous origin, leading to 
co-option/recruitment and expression of the duplicated gene in the 
venom gland (Fig. 4e,f and Extended Data Fig. 4)19,35,42.
Minimal core venom-ome toxin genes. Analysis of multi-tissue 
transcriptome data from 26 samples representing 14 different tissues 
(Supplementary Table 1a) identified 19,426 expressed genes (counts 
per million (CPM) >1; Fig. 3 and Supplementary Table 7a,b), of 
which 6,601 common core genes were expressed across all tissues 
(Supplementary Note).
The venom gland transcriptome (venom-ome) comprised 
12,346 expressed genes that included 139 genes from 33 different 
toxin gene families. Furthermore, differential expression analy-
sis revealed a set of 109 genes from 15 different toxin gene fami-
lies that were significantly upregulated in the venom gland (fold 
change >2 and 1% false discovery rate (FDR); Extended Data Fig. 
5 and Supplementary Table 7c), and this included 19 toxin genes 
that were expressed exclusively in the venom gland (Fig. 4g and 
Supplementary Note). These 19 VST genes are likely to encode the 
core venom effector toxin proteins, consisting of six neurotoxins, 
one cytotoxin, one cardiotoxin, one muscarinic toxin, six SVMPs, 
nerve growth factor (NGF-β), two venom Kunitz serine proteases 
and a CRISP (Supplementary Table 6b, column L). Additionally, 
we confirmed the presence of 16 of the 19 VSTs at the protein level 
using mass spectrometry (Supplementary Table 8).
Functionally diverse 3FTxs. Three-finger toxins are short poly-
peptides (60–90 amino acids) that belong to a superfamily of non-
enzymatic proteins found primarily in elapid snakes43. These small 
proteins are known to primarily target neuronal receptors including 
nicotinic acetylcholine receptors (nAChRs), muscarinic acetylcho-
line receptors, calcium channels and other proteins43. Structurally, 
they fold into an outstretched, three-finger-like structure where 
each finger contains a β-hairpin loop that extends from a disulfide 
bond-stabilized hydrophobic core44,45. 3FTxs typically contain four 
conserved disulfide bridges, with some containing a fifth disulfide 
bridge46. Functionally, 3FTxs are broadly classified as neurotoxins, 
cytotoxins, cardiotoxins and anticoagulants.
While expression of all 19 annotated N. naja 3FTxs was detected 
in the venom gland, 9 were specific to the venom gland. Of these 
19 3FTxs, 14 were classified as conventional 3FTxs with 8 conserved 
Cys residues, while 4 3FTxs contained 10 Cys residues. Homology-
based assessment enabled classification of the 3FTxs into seven 
neurotoxins, six cytotoxins, four cardiotoxins, one muscarinic toxin 
and one anticoagulant (Supplementary Table 9). The neurotox-
ins included two type I short-chain neurotoxins (Nana002KS and 
Nana005KS), known to interact with muscle nAChR, one type II 
long-chain neurotoxin (Nana012KS), known to target muscle and 
neuronal nAChRs, and three putative type III weak neurotoxins 
containing 10 conserved cysteines (Nana001KS, Nana003KS and 
Nana004KS), a characteristic feature of both non-conventional 
and prey-specific 3FTxs47,48. Nana018KS was structurally similar to 
Table 1 | N. naja assembly summary statistics
Assembly Contigs (n) Scaffolds (n) Gaps (Gb, %) Contig N50 
(Mb)
Scaffold N50 
(Mb)
Assembly size (Gb)
Nana_v1 (long-read (LR)) 13,066 – – 0.31 – 1.66
Nana_v2 (LR + Chicago) 13,066 2,676 0.01 (0.6) 0.31 4.90 1.67
Nana_v3 (optical map (OM)) – 1,477 – – 16.30 1.63
Nana_v4 (v3 + OM) 13,066 2,167 0.11 (6.4) 0.31 157.50 1.79
Nana_v5 (v4 + Hi-C) 13,066 1,897 0.11 (6.4) 0.30 223.35 1.79
Table 2 | Comparison of Nana_v5 assembly to other high-quality genomes
Assembly Human GRCh38 Goat ARS1 King cobra Five-pace viper Indian cobra
Total sequence length (Gb) 3.2 2.9 1.66 1.47 1.79
Total assembly gap length (Mb) 160 38 210 82 110
Number of scaffolds 735 29,907 296,399 160,256 1,897
Number of scaffolds >10 Mb (% of 
assembly)
23 (99.8) 31 (90.1) 35 (2.7) 412 (72.0) 19 (94.9)
Scaffold N50 (Mb) 67.79 87.27 0.24 2.12 223.35
Number of chromosomes 23 31 18 18 19
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haditoxin from the king cobra and known to block α7-nAChRs49. 
Further assessment by structural modeling classified the Indian 
cobra 3FTxs into four groups (Fig. 5, Extended Data Fig. 6 and 
Supplementary Table 10). The aromatic residue (Tyr25 or Phe27), 
crucial for proper folding50 and stability of the antiparallel β-sheet 
structure, was found to be conserved in all 19 3FTxs (Fig. 5a). 
Three of the four 10-Cys-residue-containing 3FTxs were non-con-
ventional 3FTxs containing a pair of additional cysteines in loop I, 
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resulting in a longer N terminus loop that could potentially also 
play a role in stabilizing this loop and contribute to toxin function47  
(Fig. 5a,b). The other 10-Cys 3FTx was a long-chain neurotoxin that 
contained a pair of additional cysteines in loop II (Nana012KS). The 
charged amino acid residue Arg39, which typically stabilizes native 
toxin conformation by forming a salt bridge with the C terminus51, 
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was conserved in all identified 3FTxs except in Nana012KS, where 
it was replaced by a leucine residue (Fig. 5a). The homology model 
of this protein indicated that Leu39 may exhibit van  der Waals 
interactions and form part of a hydrophobic core comprising Ile35, 
Phe4, Thr22 and Arg68 (Fig. 5c). Two of the cytotoxins, Nana008KS 
and Nana010KS, had shorter loops I and III compared to the other 
3FTxs (Fig. 5d).
Of note, Nana005KS contained nine Cys residues and such 
unusual 3FTxs have been found in only two other elapids, Micrurus 
lemniscatus and Micrurus altirostris52. This free Cys residue at posi-
tion 16 that precedes the conserved second Cys in loop I (Fig. 5b) 
probably facilitates the formation of covalent homo- or heterodi-
meric 3FTxs (Supplementary Table 10). Nana005KS was closely 
related to the short-chain 3FTx Nana002KS and contained a major-
ity of the residues required for activity against muscle nAChRs. 
For instance, the presence of the positively charged residues Lys25, 
Lys26 and Arg32 indicates that these toxins might be crucial for 
envenomation in mammals. In particular, the guanidyl group of 
Arg32 mimics acetylcholine forming a cation–π interaction with 
α–α and α–δ interfaces in the nAChRs53.
Acquired mutations affecting the neurotoxin binding site 
of nAChR have rendered certain species, such as the Egyptian 
mongoose (Herpestes ichneumon), immune to snake venom54–56. 
Comparison of N. naja nAChR sequence and H. ichneumon 
nAChR and other representative mammalian species showed that 
the N. naja nAChR carries a key p.Phe189Asn alteration in the 
α-neurotoxin site, known to result in decreased sensitivity to short- 
and long-chain neurotoxins55,56 (Extended Data Fig. 7).
In the final group of 3FTxs, Nana013KS was structurally similar 
to AncTx-1 (ref. 57), a synthetic ancestral toxin known to interact 
with β-adrenergic G-protein-coupled receptors. The 3FTx encoded 
by Nana006KS was found to be a close homolog of ringhalexin, 
an inhibitor of the extrinsic tenase coagulation complex, from 
Hemachatus haemachatus, the African ringhals cobra58 (Fig. 5e 
and Supplementary Table 9). Additionally, we found Nana017KS to 
be 97% similar to a recently reported Naja atra (μ-EPTX-Na1a)59 
Nav1.8 voltage-gated sodium channel inhibitor.
To understand the consequences of genetic variation in the 3FTx 
family, we assessed the rate of evolution of the major toxin families 
by computing the numbers of synonymous (KS) and non-synony-
mous (KA) nucleotide substitutions per site for each pairing of toxin 
gene and its non-toxin paralog. The KA/KS substitution ratio for the 
3FTx toxin genes was 2.034 (±0.818), while that of the non-toxin 
paralogs (Ly-6/UPAR domain-containing genes) was 0.894 (±0.103; 
Fig. 5g). The observed high KA/KS ratio (>1) indicated diversifying 
selection leading to rapid divergence and functional diversification 
of the venom-gland-specific 3FTx genes.
Indian cobra SVMP, CRISPs, PLA2, CVF and growth factor genes. 
We detected six venom-gland-specific SVMPs that belonged to the 
P-III class of metalloproteinases (with metalloproteinase/disintegrin/
Cys-rich domains) known to be involved in the induction of hemor-
rhage, inflammation, apoptosis, prothrombin activation and inhibi-
tion of platelet aggregation60. The Indian cobra SVMPs were found 
to evolve less rapidly than 3FTx genes, because the KA/KS ratio for the 
venom-gland-specific SVMPs was 1.070 (±0.137) when compared 
to 0.998 (±0.049) observed for metalloprotease domain-containing 
paralogs (Extended Data Fig. 8). The Indian cobra SVMPs formed a 
separate cluster compared with the viperid SVMPs (Extended Data 
Fig. 9). In agreement with this, a seventh Cys residue in domain M12, 
involved in the disulfide bond exchange for autolysis during secretion 
or formation of the biologically active disintegrin/Cys-rich domain 
typical of Viperidae SVMP-PIIIs60, was absent (Extended Data Fig. 9).
We also detected six CRISPs in the venom gland transcrip-
tome that were highly conserved across different snake species 
(Supplementary Fig. 1). Venom CRISPs have a wide variety of 
biological effects, including blockade of K+ and/or Ca2+ currents 
in neurons and blockage of vascular smooth muscle contraction61. 
Two of the five CRISPs were homologous to venom CRISPs from 
the Chinese cobra, Naja atra (natrin), and the monocled cobra, Naja 
kaouthia (UniProtKB: Q7T1K6). Expression of the N. naja natrin 
homolog (Nana02866) was venom gland specific, and it probably 
functions as a Kv1.3 potassium channel blocker62.
Additionally, two group I secretory acidic PLA2 genes 
(Nana39244 and Nana39246) that were highly expressed in the 
venom and salivary glands showed a high degree of similarity to 
other elapid venom PLA2s, and contained the characteristic cal-
cium-binding (XCGXGG) and catalytic (DXCCXXHD) motifs63 
(Supplementary Fig. 2 and Supplementary Note).
In addition to the major elapid toxin families described above, 
we detected transcripts from other toxin gene families including 
hyaluronidases, phospholipase B-like genes, cathelicidins, ohanin 
(known to induce hypolocomotion and hyperalgaesia)64 and 
5′ nucleotidases (Supplementary Note). We also detected l-amino 
acid oxidase (LAAO) (Nana07858), which is involved in platelet 
aggregation, edema and hemorrhage. Furthermore, we identified 
two full-length c-type natriuretic peptide genes, Nana20849 and 
Nana20852, in the venom-ome. Of the three Kunitz serine protease 
inhibitors detected in the venom-ome, two were VST gene products 
(Nana13192 and Nana13193) and these probably function to inhibit 
serine proteases acting in the hemostatic system65. In addition, two 
full-length cystatin genes, Nana15538 and Nana35841, were also 
found expressed in the venom-ome.
Cobra venom factor is a non-lethal protein that resembles the 
complement C3 protein in structure and function66. Previously, the 
complete structure of one CVF gene from N. Naja has been reported67. 
In the present study, we identified three CVF genes (Nana10828, 
Nana38416 and Nana10826) in the N. naja genome. Nana38416 
and Nana10828 contained 40 exons and spanned ~118 and ~75 kb, 
respectively, on chromosome 2. Isoform sequencing (Iso-seq) data 
confirmed the expression of the full-length transcripts correspond-
ing to Nana10828 and Nana38416. Though the 5′ genomic structure 
of Nana10826 was not fully resolved in the currently assembly, the 
expression of the full-length transcript of Nana10826 was confirmed 
by iso-seq. Protein sequence alignment showed that Nana38416 was 
96% similar to CVF (UniProtKB: Q91132) from N. kaouthia, while 
Nana10828 was 99% similar to a previously characterized N. naja C3 
complement component protein68.
In addition to toxin components, we also identified four full-
length PDGF/VEGF-growth factor genes including vascular endo-
thelial growth factor-1 (VEGF1; Nana01393), VEGFC (Nana18254), 
platelet-derived growth factor (PDGF; Nana34300), placenta growth 
factor (PGF; Nana05337) and an insulin growth factor (IGF) gene 
and Nana04360 in the venom-ome. Furthermore, we also identified 
a venom-gland-specific nerve growth factor (NGF-β; Nana13949) 
that exhibited high homology to NGFV2 from the spitting cobra 
Naja sputratrix.
Discussion
Much of our current understanding of snake venom is based on 
proteomic studies that have provided only a partial picture of its 
components69–71. A comprehensive catalog of venom proteins, their 
expression and coding sequence is fundamental to developing a safe 
and effective antivenom15,72. Also, such a detailed catalog of venom 
components will be valuable for drug candidate prospecting.
Using next-generation sequencing in combination with emerg-
ing genomic technologies, we have generated a de novo high-qual-
ity N. naja reference genome73. The near-chromosomal assembly 
revealed regions of synteny between reptilian and avian genomes, 
consistent with their evolutionary trajectories. The high contigu-
ity of our genome enabled visualization of the striking differences 
in venom gene organization between elapid and viperid snake 
NATuRE GENETICS | VOL 52 | JANUARY 2020 | 106–117 | www.nature.com/naturegenetics114
ArticlesNature GeNetics
genomes. The locations of the major toxin gene families in the N. 
naja genome on MACs was in contrast to their presence on MICs 
in P. flavoviridis and C. viridis23,35 genomes, indicative of the differ-
ences in their chromosome and venom evolution.
Overall, we found evidence for expression of 12,346 genes that 
constitute the venom-ome, and this included 139 toxin genes of 
which 19 were designated as VSTs based on their venom-gland-
specific expression. Additionally, well-known modulators of 
venom function such as CVF, coagulation factors, protein disulfide 
isomerases, natriuretic peptides, hyaluronidases, PLA2s, phos-
pholipase B-like genes, LAAO, vascular endothelial growth factor 
(VEGF) and 5′ nucleotidases were also found to be highly expressed 
in the venom gland. It is likely that these genes, together with the 
19 VSTs, form the core toxic effector components of the venom and 
induce a wide range of symptoms including cardiovascular dys-
function, muscular paralysis, nausea, blurred vision and systemic 
effects such as hemorrhage6 (Fig. 6). We propose that neutraliza-
tion of these core venom effectors using antibodies would be an 
effective therapeutic strategy. Furthermore, given the variation in 
venom composition, cataloging the venom gland gene repertoire 
and its variation (Extended Data Fig. 10 and Supplementary Note), 
both within and across different snake species, will be important for 
developing a broadly efficacious antivenom74,75.
Snake antivenom is made by immunizing large mammals, such 
as horses, with extracted snake venom as antigen12. Such horse-
derived antibodies show variation in efficacy due to expected differ-
ences in the horse antibody response following antigen challenge6,13. 
Moreover, the heterologous nature of the antibodies leads to adverse 
treatment-related side effects6,13. Starting with a complete catalog of 
VSTs, synthetic venom of a defined composition can be generated 
using recombinant protein expression technologies76. Such a cock-
tail of recombinant core venom VST proteins can be used to raise 
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specific antibodies in horses, tested for neutralizing activity, rapidly 
cloned/synthesized and humanized to produce the next generation 
of antivenoms14,16,77. Alternatively, recombinant venom proteins can 
be used as baits against antibody phage libraries to obtain toxin-
neutralizing, activity-tested humanized synthetic antibodies16,72,78.
Genome-guided recombinantly produced venom proteins can be 
also used to characterize and improve existing horse-derived anti-
venom. In this paradigm, antibodies can be raised against recombi-
nant venom toxins that are non-immunogenic in horses and used to 
supplement current antivenom cocktails to improve their efficacy. 
Alternatively, single-cell sequencing of B cell repertoires from horses 
immunized with extracted or synthetic venom can be performed to 
identify putative neutralizing antibodies79. This information can be 
used to rapidly synthesize, humanize and identify toxin-neutraliz-
ing antibodies for the generation of synthetic antivenom.
As more high-quality snake genomes are completed and venom 
gland VSTs are cataloged, synthetic antibodies directed against 
key species-specific toxins identified from such genome initiatives 
can be combined to create potent broad-spectrum antivenom80. 
Furthermore, antibodies targeting different epitopes on recombi-
nant toxins can be developed using phage display. These recom-
binant toxin-directed antibodies can be combined to generate an 
antivenom that is likely to be more efficacious81–84.
Primary cultures of venom gland cells85 or the recently developed 
venom gland organoid cultures (Post, Y. et al., personal communi-
cation), in combination with genomic information, can provide an 
alternative, viable source of venom antigens for antivenom develop-
ment (Supplementary Note).
We believe the Indian cobra reference genome and the analysis 
presented here will facilitate innovations in antivenom develop-
ment. The genome and the associated predicted proteome will serve 
as a powerful platform for evolutionary studies of venomous organ-
isms. More importantly, the comprehensive catalog of the venom 
proteins presented here should enable drug development, in par-
ticular to treat hypertension, pain and other disorders86–88.
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Methods
Karyotyping. Briefly, blood from a female animal (NN03) was collected in a 
sodium-heparin vacutainer (Becton–Dickinson) and used for short-term (72-h) 
lymphocyte cultures as previously described89. We used phytohemagglutinin (PHA 
from Phaseolus vulgaris, 20 μg ml–1, Sigma Aldrich) as the mitogen. Additionally, 
we established primary fibroblast cultures under sterile conditions using small 
pieces (0.5 mm2) of ovarian tissue from NN03. The fibroblasts were incubated in 
MEM alpha containing nucleosides and GlutaMax (Thermo Fisher), supplemented 
with 20% fetal bovine serum (Atlanta Biologicals) and antibiotic-antimycotic 
(Thermo Fisher) at 30 °C with 5% CO2. Metaphase chromosomes were obtained 
from both lymphocyte and fibroblast cultures by arresting cells with demecolcine 
(KaryoMax, Thermo Fisher; final concentration, 0.1 μg ml–1), followed by hypotonic 
treatment with Optimal Hypotonic Solution (Rainbow Scientific) and fixation in 
methanol/acetic acid (3/1). Metaphase spreads were prepared on precleaned wet 
glass slides at room temperature. Chromosomes were stained with 5% Giemsa 
(karyoMax, Thermo Fisher) in GURR buffer (Gibco). At least 30 metaphase spreads 
were captured and analyzed for karyotyping using an Axioplan2 microscope 
(Zeiss) and Ikaros (MetaSystems) software.
Flow cytometry-based genome size estimation. We estimated genome size by 
flow cytometry using a previously described protocol90. Whole blood cells of 
the Indian cobra (NN03) were cultured for 4 d in a medium consisting of MEM 
alpha with nucleosides and GlutaMax (Thermo Fisher), 30% fetal bovine serum 
(Atlanta Biologicals) and 1% PHA (1 mg ml–1, Sigma Aldrich) at 30 °C. Blood 
cells were washed six times in sterile water and then fixed in cold ethanol. Horse 
(Equus caballus) lymphocytes from a female were separated from erythrocytes 
with a Lymphoprep (Stemcell Technologies) before being cleaned and fixed in 
the same manner as the Indian cobra cells. Next, both cell types were diluted to a 
concentration of 1 × 106 cells ml–1 and stained with propidium iodide (PI, Thermo 
Fisher). After staining, the Indian cobra and horse cells were mixed 1/1 and 
analyzed on a Becton–Dickinson Accuri C6 personal flow cytometer. Two peaks 
were observed based on the amount of PI absorbed by the cells of either species, 
and genome size was estimated using the formula: genome size (cobra) = PI 
(cobra)/PI (horse) × genome size (horse), where PI (cobra) denotes the median 
amount of PI absorbed by cobra cells, PI (horse) denotes the median amount of PI 
absorbed by horse cells, and genome size (horse) is the expected size of the horse 
genome of 2.5 Gb (EquCab3, GCA_002863925.1)91.
Samples and nucleic acid preps. A total of six animals—two from Kerala, India 
(NN01 and NN02) and four unrelated animals from the Kentucky Reptile Zoo, KY 
(NN03, NN04, NN05 and NN06)—were part of the study (Supplementary Table 
1a). Two animals from India were fresh road kills that were submitted for post-
mortem analysis to the Wayanad wildlife sanctuary forest veterinary officer, and 
were permitted to be used for this study under order no. WL10–12401/2017 from 
the Kerala forest and wildlife chief warden. A summary of tissues collected and 
processed from each animal is shown in Supplementary Table 1a. Genomic DNA 
was prepared using the Qiagen Magattract HMW DNA kit (Qiagen). RNA was 
extracted using the Qiagen RNeasy kit (Qiagen).
Genome sequencing. Libraries for ONT, PacBio SMRT and Illumina sequencing 
were constructed as per the manufacturers’ instructions using high-molecular 
weight (HMW) DNA extracted from animal NN01 liver and kidney. A total of 
71.23-Gb (~40×) PacBio RSII/Sequel, 61.8 -Gb (~34×) ONT and 117.5-Gb (~64×) 
Illumina (2 × 150-base pairs (bp)) data were generated. Additionally, paired-end 
Illumina sequencing data (2 × 150 bp) were generated for each study animal as 
indicated in Supplementary Table 1b.
BNG data generation. Purified DNA extracted from muscle tissue from animal 
NN01 was embedded in a thin agarose layer, labeled and counterstained following 
the nick, label, repair and stain (NLRS) or direct label and stain (DLS) Reagent 
Kit protocol (BNG). Samples were then loaded onto Saphyr chips and run on the 
Saphyr imaging instrument (BNG). A total of 814 and 580 Gb of optical map data 
were generated using the NLRS or DLS protocol, respectively. De novo genome 
assembly using the BNG Access software for the NLRS or DLS optical map data 
produced assemblies consisting of 3,921 and 1,477 scaffolds with scaffold N50 of 
0.88 and 16.33 Mb, respectively. Additionally, we performed BNG DNA labeling 
using DNA extracted from the ovary of NN05 for use in scaffolding with the 
10x Genomics–derived de novo assembly. A total of 400 Gb of BNG data were 
generated for this animal using the DLS protocol, resulting in a de novo optical 
map assembly consisting of 1,338 scaffolds and a scaffold N50 of 15.92 Mb.
Chicago library preparation and sequencing. Three Chicago libraries were 
prepared as described previously28 using DNA from muscle tissue corresponding 
to animal NN01 (Dovetail Genomics). Briefly, for each library, ~500 ng of HMW 
gDNA (mean fragment length, 75 kb) was reconstituted into chromatin in vitro 
and fixed with formaldehyde. Fixed chromatin was digested with DpnII, the 
5′ overhangs filled in with biotinylated nucleotides and free blunt ends were then 
ligated. After ligation, cross-links were reversed and the DNA purified from 
protein. Purified DNA was treated to remove biotin that was not internal to 
ligated fragments. The DNA was then sheared to ~350 bp mean fragment size and 
sequencing libraries were generated using NEBNext Ultra enzymes and Illumina-
compatible adapters. Biotin-containing fragments were isolated using streptavidin 
beads before PCR enrichment of each library. The libraries were sequenced on 
an Illumina platform. We produced 2 × 150-bp reads and about 525 million, 
489 million and 516 million reads for libraries 1, 2 and 3, respectively. Together, 
these Chicago library reads provided ~250× (459-Gb) physical coverage of the 
genome (1–50 kb pairs).
Hi-C library preparation and sequencing. Two Dovetail Genomics Hi-C libraries 
were prepared as described previously29 using muscle tissue from animal NN01. 
Briefly, for each library, chromatin was fixed in place with formaldehyde in 
the nucleus and then extracted. Fixed chromatin was digested with DpnII, the 
5′ overhangs filled in with biotinylated nucleotides and then free blunt ends were 
ligated. After ligation, cross-links were reversed and the DNA purified to remove 
proteins. Purified DNA was treated to remove biotin that was not internal to 
ligated fragments. The DNA was then sheared to ~350-bp mean fragment size and 
sequencing libraries were generated using NEBNext Ultra enzymes and Illumina-
compatible adapters. Biotin-containing fragments were isolated using streptavidin 
beads before PCR enrichment of each library. The libraries were sequenced on 
an Illumina platform to generate 242 million and 291 million 2 × 150-bp reads for 
libraries 1 and 2, respectively. Together, these Dovetail Hi-C library reads provided 
~89×  (159 Gb) physical coverage of the genome (1–50 kb pairs).
10x Genomics library generation and sequencing. High-molecular-weight DNA 
was extracted from a female (NN05) ovary using the 10x Chromium HMW DNA 
extraction protocol (10x Genomics). With 1 ng of template, DNA whole-genome 
sequencing libraries were prepared using the Chromium Genome Library and Gel 
Bead Kit v.2 (10x Genomics, no. 120258), Chromium Genome Chip Kit v.2 (10x 
Genomics, no. 120257), Chromium i7 Multiplex Kit (10x Genomics, no. 120262) 
and Chromium controller (10x Genomics). In total, 761.34 million linked-reads 
(114 Gb, 2 × 150-bp) were generated providing a raw coverage of ~65×.
Scaffold to chromosome mapping. We used the synteny between Elaphe 
chromosomes and the N. naja Nana_v5 genome to assign scaffolds to 
chromosomes. Briefly, 105 cDNA sequences corresponding to E. quadrivirgata 
chromosomes31 were downloaded from the NCBI nucleotide database. The 
cDNA sequences were aligned to the N. naja Nana_v5 genome assembly using 
Exonerate92. The chromosome number corresponding to the Elaphe cDNA marker 
was assigned to the best matching Nana_v5 scaffold based on the highest sequence 
alignment score.
Snake chromosome laser capture microdissection and SChrom-seq. 
Chromosome slides for laser microdissection were prepared on Leica 0.9-µm 
POL-membrane frame steel frame slides (Leica, no. 11505188) following the 
manufacturer’s recommended protocol. About 10 µl of fixed and previously tested 
metaphase cell suspensions from ovarian (NN03) fibroblasts was dropped on a 
dry POL-membrane slide, allowed to spread by gravity and dried overnight. Air-
dried slides were placed in 50 ml of Giemsa solution (1 ml of 5% Giemsa staining 
solution per 50 ml of GURR buffer (Gibco)) for 10 min, washed three times in 
sterile water and air-dried. Laser confocal microscopy-enabled dissection of 
individual chromosomes was done with the Leica LMD 6 Laser Microdissection 
microscope (150× dry-immersion objective; HC PL FLUOTAR ×150/0.9 numerical 
aperture) and software. A total of 104 dissections were performed. Each sample 
tube containing microdissected chromosomes was lysed to release genomic DNA, 
and whole-genome amplification performed to amplify the DNA and create 
libraries with the SMARTer PicoPLEX DNA-seq kit (Takara Bio). The resulting 
250-bp single-end libraries were further amplified exponentially with primers 
containing unique Illumina dual-index barcodes suitable for Illumina sequencing. 
Data from each library were mapped to a combined reference genome including 
GRCh38 and snake (Nana_v5) using Burrows–Wheeler aligner (BWA)93 with 
default options. Mapped reads were sorted and duplicates marked with PicardTools 
(http://broadinstitute.github.io/picard/). Reads mapping to multiple loci, GRCh38, 
a combined bacterial sequence database or those with a mapping quality below 
10 were discarded. All remaining mapped reads were then used to calculate total 
counts per chromosome. Coverage data were generated with GATK94 and binned 
using 100-kb windows.
Synteny mapping and dot-plot analysis. The repeat-masked C. viridis (prairie 
rattlesnake) and A. carolinensis genomes were aligned to Nana_v5 chromosomes 
with CoGe’s SynMap program using LAST95. The 10x-BNG hybrid scaffolds 
and Nana_v5 scaffolds (>1 Mb) were aligned with Symap (v.4.2) using default 
parameters96. Chromosome painting of N. naja chromosomes with prairie 
rattlesnake chromosomes was performed using the SatsumaSynteny2 script with 
default parameters97.
RNA-sequencing. Ribonucleic acid was extracted from the venom gland, accessory 
gland, heart, lung, spleen, brain, ovary, testes, gall bladder, pancreas, kidney, liver, 
eye and tongue (Supplementary Table 1a) using the Qiagen RNeasy Kit (Qiagen). 
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PolyA RNA-sequencing (RNA-seq) libraries were prepared with 1 µg RNA from 
each tissue using the Illumina TruSeq stranded messenger RNA kit and sequenced 
on HiSeq (Illumina).
Iso-seq analysis. Total RNA from venom gland was used to generate cDNA and 
PacBio iso-seq libraries as per the manufacturer’s instructions. Size selection of 
libraries was performed using the BluePippin system (Sage Science). Sequencing 
was performed on a PacBio RSII/Sequel (Supplementary Table 5a). Full-length 
consensus isoform sequences were generated using PacBio’s SMRT portal and 
SMRTLink for the RSII and Sequel data, respectively. Arrow (https://github.com/
PacificBiosciences/GenomicConsensus) was used to polish the consensus isoforms. 
In total, 101,761 transcript isoforms were processed by the pipeline. Full-length 
transcripts (that contained a complete open reading frame) were then aligned 
to the genome using GMAP with parameters specific to long-read alignment98. 
Complete open reading frames were directly annotated with tBLASTx (v.2.2.29+)99 
against NCBI NR and TrEMBL using the same pipeline as done with whole-
genome annotation. We used these data to manually verify and correct venom-
gland-specific toxin gene annotations (Supplementary Note).
Repeat element identification. We identified the repetitive elements in the 
genome by combining both homology-based and de novo predictions. Next, we 
used a previously described reptile-specific repeat library20 with RepeatMasker 
(v.4.0.7) (http://www.repeatmasker.org) to annotate repetitive elements in the 
Indian cobra genome. We then used RepeatModeler (v.1.0.11) (http://www.
repeatmasker.org/RepeatModeler.html) to construct the species-specific repeat 
sequence libraries for the Indian cobra, and then used these as a query to identify 
repetitive elements using RepeatMasker. Finally, we retrieved a non-redundant 
annotation for each species after combining all the annotation results using the 
reptile-specific libraries and de novo repeat library.
Venom gene synteny analysis. BLASTn was used to identify homologs of 
all N. naja toxin genes (Supplementary Table 6b) in the Anolis and C. viridis 
genomes. BLASTn hits were then filtered using the following parameters: query 
coverage ≥70% and identity ≥80%. Synteny was then plotted using a publicly 
available Python script for gene synteny visualization (https://github.com/
biopython/biopython/blob/master/Doc/examples/Proux_et_al_2002_Figure_6.py).
Differential gene expression analysis. After adapter trimming and quality 
filtering, reads were aligned to Nana_v5 using STAR (v.2.6.0a)100 with default 
parameters. Gene counts per gene across all samples were calculated using 
featureCounts101. Raw gene counts were then normalized between samples using 
the CPM normalization method from the EdgeR package102 (Supplementary 
Table 7b–h). Differential expression analysis was then performed using EdgeR 
(fold change >2 and 1% FDR), and differentially upregulated genes (DUGs) 
were filtered for further analysis for each tissue that had a replicate. Gene 
Ontology-term enrichment analysis of DUGs was performed using EnrichR103,104 
(Supplementary Note).
Liquid chromatography–tandem mass spectrometry analysis of venom. 
Pooled Indian cobra venom samples obtained from Kentucky Reptile Zoo 
(10 μg per lane) were reduced with DTT (10 mM, 60 min at 37 °C), alkylated 
with iodoacetamide (20 mM, 15 min at room temperature) and separated by 
SDS–PAGE for ~1 cm on a 4–12% Bis-Tris gel. The gel was Coomassie stained 
with SimplyBlue (Invitrogen) and each lane cut into two segments based on the 
~70-kDa molecular weight marker. Gel pieces were de-stained in MilliQ water 
twice and dehydrated with NH4HCO3/50% acetonitrile (ACN) (20 min) and 
100% ACN (2 × 5 min). Digestion was performed overnight at 37 °C with trypsin 
(20 ng µl–1 in 50 mM NH4HCO3). Peptides were extracted twice in 1% formic 
acid (FA)/50% ACN, once with 100% ACN and then dried to completion. The 
sample was then reconstituted in solvent A (2% ACN/0.1% FA) and injected 
onto a 0.1 × 100-mm2 Waters Symmetry 1.7-mm BEH-130 C18 column via an 
auto-sampler for separation by reverse-phase chromatography on a NanoAcquity 
UPLC system (Waters). A dual-stage linear gradient with a flow rate of 1 μl min–1 
was applied for peptide separation, where solvent A was 0.1% FA/2% ACN/
water and solvent B was 0.1% FA/2% water/ACN. Solvent B was increased from 
2 to 25% over 35 min and then from 25 to 60% over 2 min, with a total analysis 
time of 60 min. Peptides eluting from the column were analyzed on an LTQ 
Orbitrap Elite mass spectrometer (Thermo Fisher) equipped with an Advance 
CaptiveSpray ionization source (Michrom). MS1 precursor ions were scanned 
in Fourier transform mass spectroscopy at 60,000 resolution and tandem mass 
spectrometry (MS/MS) data acquired on the 15 most abundant ions in LTQ 
linear ion trap mass spectrometer in data-dependent mode. MS/MS spectra were 
searched using the Mascot algorithm (Matrix Sciences) against a concatenated 
target-decoy database comprised of the FASTA sequences from the N. naja 
predicted proteome, Swiss-Prot entries from the Elapinae family (https://www.
uniprot.org/taxonomy/42168) and common contaminant proteins, as well as the 
reversed versions of each sequence. Peptide spectral matches were filtered using 
a linear discriminant function to a peptide FDR of 5% to identify those that 
mapped to the toxin proteins identified from the genome.
3FTx structural modeling. Three-dimensional structural models were generated 
using MOE software (Chemical Computing Group, v.0101) and homology 
modeling was performed using the AMBER10 EHT forcefield105. Representative 
sequences were first searched in the protein database and the closest hits based 
on percentage sequence identity were chosen as templates for construction of 
structural homology models and for root mean square deviation calculations 
(Supplementary Table 10).
Molecular evolutionary analysis. For pairwise comparisons of both venom-
expressed and non-venom-expressed genes, the number of nucleotide 
substitutions per synonymous (KS) and non-synonymous site (KA) for each pair 
of protein-coding genes was computed according to the Nei–Gojobori method106 
using Sqdif Plot (http://www.gen-info.osaka-u.ac.jp/~uhmin/study/sqdifPlot/
index.html).
Identification of ZRS limb enhancer deletion. To identify the ZRS enhancer 
region, sequences corresponding to this region were downloaded from ref. 107. 
BLASTn (v.2.2.29+)99 was used to identify the orthologous N. naja sequence. 
Multiple sequence alignment was performed using Clustal108.
Variant analysis. We first performed phylogenetic analysis using 
1,654 polymorphisms identified in the mitochondrial genomes using short-
read whole-genome sequence data for each of the six study animals. Briefly, 
adapter and quality trimmed reads were aligned to the N. naja mitochondrial 
genome (GenBank: DQ343648.1) using BWA93. Variant calling was performed 
using SAMtools109. The resulting alignments of all six animals were compared 
to a reference110. Multiple sequence alignment of the consensus mitochondrial 
sequence from the study animals, generated using MUSCLE108, was used to 
construct the phylogenetic tree using FigTree v.4.2.
For the genome-wide protein-coding variant analysis, whole-genome 
sequencing data for the six study animals were mapped to the Nana_v5 reference 
genome assembly using BWA93 with default options. Mapped reads were sorted 
and duplicates marked with PicardTools. Local realignment, germline variant 
calling and joint genotyping were performed using GATK (v.4.1.0.0)94,111. 
Germline variants were decomposed and normalized with vt112 and functionally 
annotated with snpEff113 against the annotated genome. Germline variants that 
had genotype calls in all samples were used to calculate percentage identity values 
between samples.
Genome heterozygosity estimation. K-mers from short-read sequencing data for 
each of the six animals used in this study were counted using Jellyfish (v.2.2.6)114 
for several values of K: 15, 17 and 21. Each computed K-mer histogram was then 
analyzed with GenomeScope115.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
Sequence data (DNA and RNA) can be accessed at NCBI under BioProject 
accession no. PRJNA527614. The MS data are available under accession no. 
MSV000084564.
Code availability
All software tools used in this study are provided in the accompanying Nature 
Research Reporting Summary document.
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Extended Data Fig. 1 | Indian cobra genome size estimation by flow cytometry. a, Gating strategy for Indian cobra (Naja naja) genome size estimation 
showing the propidium iodide (PI) positive sample within the elliptical gate. b, PI positive gated population in a histogram showing showing PI stained N. 
naja blood and Equus caballus (horse) lymphocytes. c, Table of median fluorescence intensities measured for Naja naja and Equus caballus and estimated 
genome size in Gb in 3 replicate experiments. A total of 3000 and 300 measurements were conducted for the Indian cobra and horse, respectively.
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Extended Data Fig. 2 | N. naja karyotyping. Representative karyotype obtained from cultured red blood cells from a female animal NN03. A total of N = 15 
cells were karyotyped.
NATuRE GENETICS | www.nature.com/naturegenetics
ArticlesNature GeNetics
Extended Data Fig. 3 | Genomic repeat elements identified in the Indian cobra genome. a, Bar plot of the percent distribution of the different classes 
of repeat elements in the N. naja genome (Nana_v5). b, Comparison of proportion of the repeat content among 4 published snake, green anole lizard 
genomes and the Indian cobra genome.
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Extended Data Fig. 4 | Syntenic comparisons of SVMP gene cluster. Relevant syntenic genomic regions between the Indian cobra (Nana_v5), prairie 
rattlesnake and green anole lizard genomes are shown. Orthologous gene pairs are indicated by shaded regions across the corresponding genomic regions. 
Yellow arrows with blue border indicate gene synteny, while those without colored borders represent potential species-specific duplications. SVMP, snake 
venom metalloproteinase.
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Extended Data Fig. 5 | Heatmap of differentially upregulated genes in the N. naja venom gland transcriptome. Protein families are indicated in colored bars. 
NN01 and NN02 correspond to N. naja specimens obtained from Kerala, India. NN03, NN04, NN05 and NN06 correspond to N. naja specimens obtained 
from the Kentucky reptile zoo. Expression values plotted as log2 transformed CPM values with FDR cutoff set at 1% used for differential expression analysis.
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Extended Data Fig. 6 | Pairwise structural comparison of representative N. naja 3FTxs. RMSD matrix for the structural models from 9 representative 3FTxs.
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Extended Data Fig. 7 | nAChR polymorphism in Indian cobra. Multiple sequence alignment showing the region surrounding the alpha neurotoxin binding 
site in nAChR of seven vertebrate animals and N. naja nAChR (Nana03380-RA) identified a SNP at residue 189 in the N. naja nAChR indicated by the blue 
arrow. nAChR – nicotinic acetylcholine receptor; DANRE – Danio rerio; CHICK, Gallus gallus; HERIC, Herpestes ichneumon; HUMAN, Homo sapiens; PANTR, 
Pan troglodytes; RAT, Rattus norvegicus; MOUSE, Mus musculus.
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Extended Data Fig. 8 | Molecular evolution of Indian cobra SVMP genes. KA and KS values were calculated according to the Nei-Gojobori method. KA 
and KS with values < 0.1 were not included in further analysis for reliable analysis. NVMP, Non-venomous metalloproteinase genes; SVMP, Snake venom 
metalloproteinase genes.
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Extended Data Fig. 9 | SVMP expression and comparative protein sequence alignment. a, Multiple sequence alignment of SVMP proteins from the Indian 
cobra, and representative SVMPs from other Elapid and Viperid species and human ADAM28. Arrows indicate additional cysteine residues typically 
present in the M12 domain of Viperidae SVMPs. b, Phylogenetic tree reveals distinct clusters formed by elapid and viperid SVMPs. The bar indicates 0.03 
substitutions per nucleotide position. Elapid species - OPHHA, Ophiophagus hannah; NAJAT, Naja atra; NAJMO, Naja mossambica; NAJKA, Naja kaouthia; 
Viperid species - DABRR, Daboia ruselli; AGKCL, Agkistrodon contortrix laticinctus; DEIAC, Deinagkistrodon acutus; BOTJA, Bothrops jararaca; HUMAN,  
Homo sapiens.
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Extended Data Fig. 10 | See next page for caption.
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Extended Data Fig. 10 | Genetic polymorphisms in 6 N. naja specimens. a–d, Pairwise similarity (PWS) matrices based on (a), all genome-wide protein-
altering variants, (b), all venom gland-expressed genes, (c), core venom-ome genes, and (d), all 3FTx genes identified in this study. e, Distribution of 
protein altering variants in 106 venom gland-specific toxin genes. f, Distribution of protein altering variants in 3FTx genes located on chromosome 3 across 
all six study animals (NN01-NN06). Within each track in (b-f), homozygous variants are shown as blue vertical lines while heterozygous variants are 
shown as red vertical lines. NN01 and NN02 correspond to N. naja specimens obtained from Kerala, India. NN03, NN04, NN05 and NN06 correspond to 
N. naja specimens obtained from the Kentucky reptile zoo. MIC, microchromosomes.
NATuRE GENETICS | www.nature.com/naturegenetics
1nature research  |  reporting sum
m
ary
O
ctober 2018
Corresponding author(s): Somasekar Seshagiri
Last updated by author(s): Nov 19, 2019
Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
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A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
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Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
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Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
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Policy information about availability of computer code
Data collection No commercial/custom code was used for data collection.
Data analysis We list here the software URLs of all open-source tools used for data analysis. 
R: https://www.R-project.org/ 
Arrow: https://github.com/PacificBiosciences/GenomicConsensus 
Canu: https://github.com/marbl/canu 
Flye: https://github.com/fenderglass/Flye 
WTDBG https://github.com/ruanjue/wtdbg2 
BUSCO: https://gitlab.com/ezlab/busco 
Jellyfish: https://www.cbcb.umd.edu/software/jellyfish/ 
GenomeScope: http://qb.cshl.edu/genomescope/ 
Repeatmasker: http://www.repeatmasker.org  
Repeatmodeler: http://www.repeatmasker.org/RepeatModeler.html 
MAKER: http://www.yandell-lab.org/software/maker.html 
SNAP: http://snap.cs.berkeley.edu 
AUGUSTUS: http://augustus.gobics.de/ 
Exonerate: https://www.ebi.ac.uk/about/vertebrate-genomics/software/exonerate 
snpEff: http://snpeff.sourceforge.net/ 
Enrichr: http://amp.pharm.mssm.edu/Enrichr 
GATK: https://software.broadinstitute.org/gatk/download/ 
BWA: https://github.com/lh3/bwa/releases 
EdgeR: https://bioconductor.org/packages/release/bioc/html/edgeR.html 
Synteny plots: https://github.com/biopython/biopython/blob/master/Doc/examples/Proux_et_al_2002_Figure_6.py 
OrthoFinder: http://www.stevekellylab.com/software/orthofinder 
STAR: https://github.com/alexdobin/STAR 
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featureCounts: http://bioinf.wehi.edu.au/featureCounts/ 
Picard: http://broadinstitute.github.io/picard/ 
Figtree: https://github.com/rambaut/figtree 
CoGe: https://genomevolution.org/coge/ 
Symap: http://www.agcol.arizona.edu/software/symap/ 
vt: https://github.com/atks/vt
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
All sequencing data that support this study have been deposited in NCBI under the BioProject accession # PRJNA527614 and can be accessed at "https://
dataview.ncbi.nlm.nih.gov/object/PRJNA527614". 
Mass spectrometry data collected in this study has been deposited at MassIVE and can be accessed via this link - "ftp://massive.ucsd.edu/MSV000084564/".
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size A total of 6 animals was used in this study as described in Table S1a and methods section.
Data exclusions No data was excluded in this study.
Replication Biological replicates, where appropriate, have been used and described in the methods section and supplementary tables
Randomization This is a de novo genome sequencing project and hence, randomization does not apply to this study.
Blinding This is a de novo genome sequencing project and hence, blinding does not apply to this study.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
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Animals and other organisms
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Clinical data
Methods
n/a Involved in the study
ChIP-seq
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MRI-based neuroimaging
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals We obtained horse blood from a horse (Equus caballus) that is a research mare at the Texas A&M Large Animal clinic. 
Species: Equus caballus 
Breed: American quarter horse 
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Age: 6 years old
Wild animals Two animals used in this study from India were fresh road kills and were approved for use in the study as described in the 
methods section.
Field-collected samples This study did not include field-collected samples
Ethics oversight This study did not require ethics approval.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
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